Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Safety and Efficacy Study of ELND005 as an Adjunctive Maintenance Treatment in Bipolar I Disorder

ClinicalTrials.gov ID: NCT01674010

Public ClinicalTrials.gov record NCT01674010. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 5:35 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Safety and Efficacy Study of Oral ELND005 as an Adjunctive Maintenance Treatment in Patients With Bipolar I Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary purpose of this study is to determine whether ELND005 is effective in the maintenance treatment of bipolar 1 disorder when added to other therapies.

Study identification

NCT ID
NCT01674010
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
OPKO Health, Inc.
Industry
Enrollment
309 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2012 (Type not available)
Primary completion
Jun 2014 (Actual)
Completion
Jun 2014 (Actual)
Last update posted
Oct 21, 2019

2012 – 2014

United States locations

U.S. sites
41
U.S. states
19
U.S. cities
39
Facility City State ZIP Site status
Elan Investigational Site Birmingham Alabama 35294 —
Elan Investigational Site Glendale Arizona 85306 —
Elan Investigational Site Phoenix Arizona 85004 —
Elan Investigational Site Little Rock Arkansas 72201 —
Elan Investigational Site Little Rock Arkansas 72211 —
Elan Investigational Site Cerritos California 90703 —
Elan Investigational Site Costa Mesa California 92626 —
Elan Investigational Site Escondido California 92025 —
Elan Investigational Site Garden Grove California 92845 —
Elan Investigational Site National City California 91950 —
Elan Investigational Site Oceanside California 92056 —
Elan Investigational Site Palo Alto California 94304 —
Elan Investigational Site Riverside California 92506 —
Elan Investigational Site San Diego California 92121 —
Elan Investigational Site Santa Ana California 92701 —
Elan Investigational Site Stanford California 94305 —
Elan Investigational Site Norwich Connecticut 06360 —
Elan Investigational Site North Miami Florida 33161 —
Elan Investigational Site Oakland Park Florida 33334 —
Elan Investigational Site Tampa Florida 33613 —
Elan Investigational Site Atlanta Georgia 30308 —
Elan Investigational Site Roswell Georgia 30076 —
Elan Investigational Site Creve Coeur Missouri 63141 —
Elan Investigational Site St Louis Missouri 63118 —
Elan Investigational Site St Louis Missouri 63128 —
Elan Investigational Site Lincoln Nebraska 68526 —
Elan Investigational Site Marlton New Jersey 08053 —
Elan Investigational Site Fresh Meadows New York 11366 —
Elan Investigational Site New York New York 10065 —
Elan Investigational Site Raleigh North Carolina 27609 —
Elan Investigational Site Beachwood Ohio 44122 —
Elan Investigational Site Cincinnati Ohio 45219 —
Elan Investigational Site Cleveland Ohio 44106 —
Elan Investigational Site Oklahoma City Oklahoma 73112 —
Elan Investigational Site Philadelphia Pennsylvania 19139 —
Elan Investigational Site Charleston South Carolina 29407 —
Elan Investigational Site Houston Texas 77054 —
Elan Investigational Site Hurst Texas 76053 —
Elan Investigational Site San Antonio Texas 78229 —
Elan Investigational Site Salt Lake City Utah 84106 —
Elan Investigational Site Bellevue Washington 98007 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 41 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01674010, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 21, 2019 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01674010 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →